Latest

psychopharmacology

Featured Open Neuroscience Articles Psychology

·October 3, 2017·5 min read

Expectations Influence Effectiveness of SSRIs

Study reveals people are three times more likely to report SSRIs are effective for their depression and anxiety when given the correct information about the medication.

Featured Neuroscience Open Neuroscience Articles Psychology

·September 6, 2017·5 min read

CBD May Protect Against Psychiatric Risk from High-THC Cannabis Strains

Researchers report CBD, a non-psychoactive compound in cannabis, can help protect against the psychiatric risks associated with THC.

Featured Psychology

·August 15, 2017·4 min read

Will Ketamine Treat Your Depression? Check Your Activity Monitor

A new study reports depressed people who responded to ketamine found their activity increased during earlier parts of the day. Researchers suggest clock gene machinery may be linked to the type of depression that responds to ketamine treatment.

Featured Neuroscience Open Neuroscience Articles Psychology

·August 15, 2017·4 min read

Weight Gain Receptor Linked to Antipsychotic Drug

A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.

Featured Open Neuroscience Articles Psychology

·August 8, 2017·4 min read

‘Ego Dissolving’ Psychedelic Drugs Could Assist With Mental Health

A new study in Neuroscience of Consciousness adds weight to previous findings about the potential benefits psychedelics could have for treating mental health disorders.

Featured Open Neuroscience Articles Psychology

·July 30, 2017·5 min read

Faster Acting Antidepressants May Finally Be Within Reach

Researchers explain how SSRI antidepressants initiate action by targeting a specific type of nerve cells. Findings may lead to the development of faster acting antidepressants.

Featured Psychology

·July 24, 2017·5 min read

Ketamnine Shows Promise in Treatment of Geriatric Depression

A new study reports ketamine may be a safe and effective method of treating depression in older people. The University of New South Wales study reveals ketamine was well tolerated by those with depression, and repeated treatments led to a higher likelihood of remission.

Featured Neuroscience Psychology

·July 20, 2017·4 min read

What Are the Effects of Stopping Psychiatric Medications?

A new study from researchers at UCLA calls for mental health professional to be more helpful to patients wishing to stop psychiatric medications.

Featured Psychology

·July 19, 2017·5 min read

Old Antibiotic Could Form New Depression Treatment

Minocycline, a broad-spectrum tetracycline antibiotic, has shown promise in the treatment of depression. Researchers say the antibiotic could help reduce brain inflammation associated with some cases of major depressive disorder. A small study conducted by researchers at Deakin University found those treated with Minocycline reported improved quality of life, reduced anxiety symptoms and a better global impression of their depression.

Featured Neuroscience

·July 10, 2017·5 min read

On-Site Ecstasy Pill Testing Service May Reduce User Risks at Concerts and Raves

Researchers from Johns Hopkins University have found that free ecstasy pill testing at raves and concerts could have a positive impact in preventing some people from using adulterated drugs. The study, researchers say, adds to critical evidence that on site pill testing is a valuable tool for public health and safety.